mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-10 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-10 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
3e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-09 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-09 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-09 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-08 |